source
- Boehringer Ingelheim to invest up to $1B in AI-driven solid tumor partnership with EnvisagenicsBoehringer Ingelheim announced a partnership with Envisagenics to develop precision oncology therapies that use artificial intelligence to identify cancer-specific RNA splicing alterations. The co…
- Siemens Healthineers partners with Novo to raise awareness and testing for fatty liver diseaseSiemens Healthineers and Novo have announced a collaboration aimed at increasing awareness and improving diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progre…